Related Experiment Video
Updated: Sep 17, 2025

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Epigenetic Mechanisms in Neuroendocrine Neoplasms: Is There a Place for Inhibitors of DNA Binding Proteins?
David Sanchis-Pascual1, María Isabel Del Olmo-García1,2, Pilar Morillas-Amat3
1Endocrinology and Nutrition Department, University and Politecnic Hospital La Fe (Valencia), 46026 Valencia, Spain.
Abstract:
Inhibitors of DNA-binding (Id) proteins constitute a family of repressor factors that modulate a multitude of cellular processes and have been linked to tumor aggressiveness, resistance to chemotherapy, angiogenesis, and worse prognosis in numerous malignancies. This review explores the role of Id proteins in the pathogenesis of neuroendocrine neoplasms (NENs). The findings revealed that this family of proteins shows significant overexpression in tumors such as small cell lung carcinoma (SCLC), neuroendocrine prostate carcinoma (NEPC), and medullary thyroid carcinoma (MTC), although the role of epigenetics in regulating Id proteins within NENs remains poorly understood, with most evidence limited to NEPC. These results underscore the potential of Id proteins not only as diagnostic biomarkers and promising therapeutic targets for the management of NENs, but also highlight the need for further research to better understand their epigenetic regulation and broader role in these tumors.
Insights
Inhibitors of DNA-binding (Id) proteins are overexpressed in neuroendocrine neoplasms (NENs), suggesting their potential as diagnostic biomarkers and therapeutic targets for these aggressive tumors.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Pathogenesis
Background:
- Inhibitors of DNA-binding (Id) proteins are repressor factors influencing cellular processes.
- Id proteins are implicated in tumor aggressiveness, chemotherapy resistance, and poor prognosis across malignancies.
Purpose of the Study:
- To review the role of Id proteins in the pathogenesis of neuroendocrine neoplasms (NENs).
- To highlight Id proteins as potential diagnostic and therapeutic targets for NENs.
Main Methods:
- Literature review focusing on Id protein expression and regulation in NENs.
- Analysis of existing data on Id protein involvement in small cell lung carcinoma, neuroendocrine prostate carcinoma, and medullary thyroid carcinoma.
Main Results:
- Significant overexpression of Id proteins was observed in small cell lung carcinoma (SCLC), neuroendocrine prostate carcinoma (NEPC), and medullary thyroid carcinoma (MTC).
- The epigenetic regulation of Id proteins in NENs is largely uncharacterized, with limited data primarily from NEPC.
Conclusions:
- Id proteins represent promising diagnostic biomarkers and therapeutic targets for NEN management.
- Further research is crucial to elucidate the epigenetic regulation and comprehensive role of Id proteins in NENs.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Mitogens and the Cell Cycle
Abnormal Proliferation
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

